These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1823 related items for PubMed ID: 10604039

  • 1. Pharmacokinetics of NS-105, a novel cognition enhancer. 1st communication: absorption, metabolism and excretion in rats, dogs and monkeys after single administration of 14C-NS-105.
    Mukai H, Sugimoto T, Ago M, Morino A.
    Arzneimittelforschung; 1999 Nov; 49(11):881-90. PubMed ID: 10604039
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics of NS-49, a phenethylamine class alpha 1A-adrenoceptor agonist. 1st communication: absorption and excretion in rats after a single administration of 14C-NS-49.
    Mukai H, Watanabe S, Morino A.
    Arzneimittelforschung; 1999 May; 49(5):434-40. PubMed ID: 10367106
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetics of the new pyrimidine derivative NS-7, a novel Na+/Ca2+ channel blocker. 1st communication: plasma concentrations and excretions after a single intravenous 14C-NS-7 injection to rats, dogs and monkeys.
    Nonaka K, Tsujioka T, Tougou K, Mukai H.
    Arzneimittelforschung; 2003 May; 53(9):612-20. PubMed ID: 14558434
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 1st communication: plasma concentrations, metabolism and excretion after a single intravenous administration to rats, dogs and monkeys.
    Sugimoto T, Hayashi T, Okita A, Morino A.
    Arzneimittelforschung; 1996 Feb; 46(2):106-13. PubMed ID: 8720298
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics of NS-105, a novel cognition enhancer. 2nd communication: distribution and transfer into fetus and milk after single administration, and effects of repeated administration on pharmacokinetics and hepatic drug-metabolizing enzyme activities in rats.
    Mukai H, Sugimoto T, Ago M, Morino A, Takaichi M, Ogawa Y, Seki H, Matsuura C, Esumi Y.
    Arzneimittelforschung; 1999 Dec; 49(12):977-85. PubMed ID: 10635441
    [Abstract] [Full Text] [Related]

  • 6. Pharmacokinetics of prulifloxacin. 1st communication: absorption, distribution and excretion in rats, dogs and monkeys after a single administration.
    Okuyama Y, Momota K, Morino A.
    Arzneimittelforschung; 1997 Mar; 47(3):276-84. PubMed ID: 9105546
    [Abstract] [Full Text] [Related]

  • 7. Pharmacokinetics of NS-49, a phenethylamine class alpha 1A-adrenoceptor agonist. 2nd communication: Absorption and excretion in rabbits, dogs and monkeys after a single administration of 14C-NS-49.
    Mukai H, Watanabe S, Morino A.
    Arzneimittelforschung; 1999 Jun; 49(6):527-32. PubMed ID: 10417870
    [Abstract] [Full Text] [Related]

  • 8. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
    Matsumoto S, Tagawa M, Amejima H, Nakao M, Kagemoto A, Fujii T, Miyazaki H, Sekine Y.
    Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675
    [Abstract] [Full Text] [Related]

  • 9. Pharmacokinetics of 4-acetylaminophenylacetic acid. 1st communication: absorption, distribution, metabolism and excretion in mice, rats, dogs and monkeys after single administration of 14C-labeled compound.
    Sugihara K, Morino A, Nomura A, Iida S, Sugiyama M.
    Arzneimittelforschung; 1990 Jul; 40(7):800-5. PubMed ID: 2222556
    [Abstract] [Full Text] [Related]

  • 10. Pharmacokinetics of (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate. 1st communication: absorption, distribution and excretion after single administration of 14C-labeled compound to rats and dogs.
    Nakamura A, Sugihara K, Hirota T, Morino A, Ezumi Y, Takaichi M.
    Arzneimittelforschung; 1997 Feb; 47(2):151-9. PubMed ID: 9079234
    [Abstract] [Full Text] [Related]

  • 11. Pharmacokinetics of NS-49, a phenethylamine class alpha 1A-adrenoceptor agonist. 3rd communication: metabolism in rats, rabbits, dogs and monkeys, and effects on hepatic drug-metabolizing enzyme activities in rats after repeated administration.
    Mukai H, Watanabe S, Morino A.
    Arzneimittelforschung; 1999 Jul; 49(7):612-7. PubMed ID: 10442210
    [Abstract] [Full Text] [Related]

  • 12. Pharmacokinetics of (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate. 3rd communication: plasma concentrations of the unchanged drug and its deethylated metabolite in rats, dogs and monkeys.
    Nakamura A, Hirota T, Sugihara K, Morino A.
    Arzneimittelforschung; 1997 Feb; 47(2):169-74. PubMed ID: 9079236
    [Abstract] [Full Text] [Related]

  • 13. Absorption, distribution, metabolism and excretion of [14C]ebastine after a single administration in rats.
    Fujii T, Matsumoto S, Amejima H, Hatoyama T, Nakao M, Kagemoto A, Tanaka K, Miyazaki H.
    Arzneimittelforschung; 1994 Apr; 44(4):527-38. PubMed ID: 7912071
    [Abstract] [Full Text] [Related]

  • 14. Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl] benzoic acid. 4th communication: absorption, metabolism, excretion and plasma protein binding in various animals and man.
    Mizojiri K, Okabe H, Sugeno K, Misaki A, Ito M, Kominami G, Esumi Y, Takaichi M, Harada T, Seki H, Inaba A.
    Arzneimittelforschung; 1997 Mar; 47(3):259-69. PubMed ID: 9105544
    [Abstract] [Full Text] [Related]

  • 15. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
    Yamaguchi T, Nakajima Y, Mizobuchi M, Inazawa K, Kanazu T, Kadono K, Ohkawa T, Iwatani K.
    Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
    [Abstract] [Full Text] [Related]

  • 16. Pharmacokinetics of nisoldipine. I. Absorption, concentration in plasma, and excretion after single administration of [14C]nisoldipine in rats, dogs, monkey, and swine.
    Ahr HJ, Krause HP, Siefert HM, Suwelack D, Weber H.
    Arzneimittelforschung; 1988 Aug; 38(8):1093-8. PubMed ID: 3196402
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetics, tissue distribution, and excretion of sitafloxacin, a new fluoroquinolone antibiotic, in rats, dogs, and monkeys.
    Tachibana M, Tanaka M, Mitsugi K, Jin Y, Takaichi M, Okazaki O.
    Arzneimittelforschung; 2004 Aug; 54(12):898-905. PubMed ID: 15646375
    [Abstract] [Full Text] [Related]

  • 18. The pharmacokinetics of nitrendipine. I. Absorption, plasma concentrations, and excretion after single administration of [14C]nitrendipine to rats and dogs.
    Krause HP, Ahr HJ, Beermann D, Siefert HM, Suwelack D, Weber H.
    Arzneimittelforschung; 1988 Nov; 38(11):1593-9. PubMed ID: 3214442
    [Abstract] [Full Text] [Related]

  • 19. Pharmacokinetics and metabolism of the new thromboxane A2 receptor antagonist ramatroban in animals. 1st communication: absorption, concentrations in plasma, metabolism, and excretion after single administration to rats and dogs.
    Boberg M, Ahr HJ, Beckermann B, Bühner K, Siefert HM, Steinke W, Wünsche C, Hirayama M.
    Arzneimittelforschung; 1997 Aug; 47(8):928-38. PubMed ID: 9296279
    [Abstract] [Full Text] [Related]

  • 20. Pharmacokinetics, protein binding and metabolic profile of 3H-icometasone enbutate following intravenous, oral and intratracheal administrations to Sprague-Dawley rats.
    Duchêne P, Giudicelli MD, Neau B, Gronfier A, Firmin Y, Villax P, Saivin S, Houin G.
    Arzneimittelforschung; 1998 Apr; 48(4):371-8. PubMed ID: 9608879
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 92.